A Phase II Randomized Study of Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care Alone in Patients With Advanced Colorectal Adenocarcinoma Refractory to Standard Therapies
The standard or usual treatment for this disease is treatment with drugs and other
treatments that may help to make a patient better or may improve their quality of life. This
treatment is known as "best supportive care" (BSC). Although patients with best supportive
care can feel better for some months, the cancer usually continues to grow.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society